510(k) Report

510(k) · Cleared

Cleared

ARCHIMEDES Biodegradable Stent (Medium)

K260835510(k) TraditionalCleared Jul 27, 2026136-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.) · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Jul 27, 2026 as substantially equivalent to K243412 (Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.), 2025) and 1 other predicate after a 136-day review. Its family tree reaches back 5 generations to 1984.

Decided
Jul 27, 2026
Review
136 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K834468 (1984). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK834468 Drainage StentMicrovasive · 1984 · Recalled
  2. 4 generations backK965147 Biliary Stent, Biliary Stent System, Biliary EndoprosthesisBoston Scientific Corp · 1997 · Recalled
  3. 3 generations backK101314 Advanix Biliary Stent with Naviflex RX Delivery SystemBoston Scientific Corp · 2010
  4. 2 generations backK133700 Advanix Pancreatic Stent and Naviflex Rapid Exchange Pancreatic…Boston Scientific Corporation · 2014 · Recalled
  5. 1 generation backK243412 ARCHIMEDES Biodegradable Pancreatic StentQ3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.) · 2025
  6. This deviceK260835 ARCHIMEDES Biodegradable Stent (Medium)Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.) · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K834468Drainage StentMicrovasive19842
−4K965147Biliary Stent, Biliary Stent System, Biliary EndoprosthesisBoston Scientific Corp199723
−3K101314Advanix Biliary Stent with Naviflex RX Delivery SystemBoston Scientific Corp2010—
−2K133700Advanix Pancreatic Stent and Naviflex Rapid Exchange Pancreatic Delivery…Boston Scientific Corporation201413
−1K243412ARCHIMEDES Biodegradable Pancreatic StentQ3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.)2025—
0 (this device)K260835ARCHIMEDES Biodegradable Stent (Medium)Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.)2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199410
202010
FIG. 1 — Lineage of K260835, 1984–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K243412ARCHIMEDES Biodegradable Pancreatic Stent
Summary page 5
…d accessories 3. Predicate Device (Pancreatic indication) Trade Name: ARCHIMEDESTM Biodegradable Pancreatic Stent (Fast) Clearance Number: K243412 Common Name: Pancreatic Stent Product Code: FGE Device Class: Class II Device Pane…
Q3 Medical USA, LLC (C/O Q3 Medical Devices Ltd.)2025—
*K203162Advanix Biliary Stent with NaviFlex RX Delivery System
Summary page 6
…iliary indication) Trade Name: Advanix™ Biliary Stent with NaviFlex™ RX Delivery System Clearance Number: K203162 Common Name: Stents, Drains, and Dilators for the Biliary Ducts Product Code: FGE Device Clas…
Boston Scientific Corporation2020—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 42 years and passes through 4 companies; a new generation was cleared every 11.2 years on median.
  • 4 of the 8 ancestors have a recall of any class.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The ARCHIMEDES Biodegradable Stent (Medium) is intended to drain biliary ducts in patients indicated for biliary duct stenting.

The ARCHIMEDES Biodegradable Stent (Medium) is intended to drain pancreatic ducts in patients indicated for pancreatic duct stenting.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260835: ARCHIMEDES Biodegradable Stent (Medium).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K260835

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026